Trademark Alertz
Search
Search Australian Trademarks
Trademark
Owner
19
trademarks were found for
owners
matching the name
Adamas Pharmaceuticals, Inc.
.
#
Class
status
1
S:
88059617
M:
ACCESS OSMOLEX
O:
ADAMAS PHARMA, LLC
,
ADAMAS PHARMACEUTICALS, INC.
,
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
42
Registered
2
S:
87639712
M:
OSMOLEX ER
O:
ACELLA HOLDINGS, LLC
,
ADAMAS PHARMA, LLC
,
ADAMAS PHARMACEUTICALS, INC.
,
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
5
Registered
3
S:
87411723
M:
OSMOLEX
O:
ACELLA HOLDINGS, LLC
,
ADAMAS PHARMA, LLC
,
ADAMAS PHARMACEUTICALS, INC.
,
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
5
Registered
4
S:
86698537
M:
KOBILTI
O:
ADAMAS PHARMA LLC
,
Adamas Pharmaceuticals, Inc.
5
Dead
5
S:
86698547
M:
KOTIMLI
O:
ADAMAS PHARMA LLC
,
Adamas Pharmaceuticals, Inc.
5
Dead
6
S:
86698560
M:
ZIMRALI
O:
ADAMAS PHARMA LLC
,
Adamas Pharmaceuticals, Inc.
5
Dead
7
S:
86698579
M:
BALCOVRI
O:
ADAMAS PHARMA LLC
,
Adamas Pharmaceuticals, Inc.
5
Dead
8
S:
86698587
M:
GOCOVRI
O:
ADAMAS PHARMA LLC
,
Adamas Pharmaceuticals, Inc.
5
Registered
9
S:
86050252
M:
A ADAMAS
O:
Adamas Pharmaceuticals, Inc.
5
Registered
10
S:
86050262
M:
ADAMAS
O:
Adamas Pharmaceuticals, Inc.
5
Registered
11
S:
85894899
M:
NURELIN
O:
Adamas Pharmaceuticals, Inc.
5
Dead
12
S:
85490826
M:
ARIMENDA
O:
Adamas Pharmaceuticals, Inc.
5
Dead
13
S:
77821874
M:
KINEDINE
O:
Adamas Pharmaceuticals, Inc.
5
Dead
14
S:
77821888
M:
VIMANTA
O:
Adamas Pharmaceuticals, Inc.
5
Dead
15
S:
77821907
M:
NURELIN
O:
Adamas Pharmaceuticals, Inc.
5
Dead
16
S:
77191117
M:
A ADAMAS
O:
ADAMAS PHARMACEUTICALS, INC.
,
NeuroMolecular Pharmaceuticals, Inc.
5
Dead
17
S:
77977587
M:
A ADAMAS
O:
ADAMAS PHARMACEUTICALS, INC.
,
NeuroMolecular Pharmaceuticals, Inc.
5
Dead
18
S:
77189027
M:
ADAMAS
O:
ADAMAS PHARMACEUTICALS, INC.
,
NeuroMolecular Pharmaceuticals, Inc.
5
Dead
19
S:
77977588
M:
ADAMAS
O:
ADAMAS PHARMACEUTICALS, INC.
,
NeuroMolecular Pharmaceuticals, Inc.
5
Dead
Trademark Alertz updated from USPTO on 2030-01-24